Compare AMP & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMP | MDLN |
|---|---|---|
| Founded | 1894 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 37.4B |
| IPO Year | 2009 | N/A |
| Metric | AMP | MDLN |
|---|---|---|
| Price | $524.95 | $39.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $544.91 | $50.48 |
| AVG Volume (30 Days) | 621.8K | ★ 7.9M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | ★ 9.77 | N/A |
| EPS | ★ 9.68 | N/A |
| Revenue | ★ $18,911,000,000.00 | N/A |
| Revenue This Year | $1.79 | $10.88 |
| Revenue Next Year | $4.20 | $7.69 |
| P/E Ratio | ★ $54.56 | $658.75 |
| Revenue Growth | ★ 5.49 | N/A |
| 52 Week Low | $422.37 | $32.82 |
| 52 Week High | $550.18 | $50.88 |
| Indicator | AMP | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 68.93 | 46.70 |
| Support Level | $489.57 | $38.08 |
| Resistance Level | $550.18 | $43.87 |
| Average True Range (ATR) | 14.37 | 1.54 |
| MACD | 2.82 | -0.28 |
| Stochastic Oscillator | 84.51 | 13.53 |
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating profit from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.